ArticleIn vivo (Athens, Greece)
Clinicopathological Characteristics of Atypical Polypoid Adenomyoma of the Uterus in Association With Endometrial Atypical Hyperplasia and Endometrioid Carcinoma.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimAtypical polypoid adenomyoma (APA) is an uncommon biphasic uterine tumor characterized by irregularly shaped, atypical endometrial glands haphazardly distributed within a fibromuscular stroma. APA is frequently associated with atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AH/EIN) and endometrioid endometrial carcinoma (EC). This study aimed to characterize the clinicopathological features and outcomes of APA concomitant with AH/EIN and EC. PATIENTS AND
methodsNineteen cases of APA coexisting with AH/EIN or EC were retrospectively analyzed. Clinical presentation, pathological findings, treatment modalities, and outcomes were reviewed.
resultsMost patients (78.9%) were of reproductive age (26-45 years). The most common presenting symptom was abnormal uterine bleeding (47.4%), while 26.3% were asymptomatic. EC and AH/EIN were identified in 14 (73.7%) and five (26.3%) patients, respectively. Compared with AH/EIN, EC more often demonstrated cribriform architecture, papillary intraluminal growth, and stromal desmoplasia. Six of the 14 patients with EC underwent hysterectomy and remained recurrence-free. Of the eight patients managed with progestin therapy, four had persistent EC or AH/EIN on follow up curettage at three months. Similarly, one of the five patients with AH/EIN treated conservatively showed persistent disease after three months of progestin therapy. Nevertheless, all patients were disease-free at the last follow-up.
conclusionIn APA, meticulous pathological evaluation is essential to detect concurrent AH/EIN or EC. Although conservative management may be appropriate for selected patients, close surveillance is necessary to monitor for persistence or recurrence. Hysterectomy remains a definitive and reliable therapeutic option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.